Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer

References

• Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4:143-53; PMID:14732866; http://dx.doi.org/10.1038/nrc1279
   PubMed Web of Science ®Google Scholar
• Herman JG. Hypermethylation of tumor suppressor genes in cancer. Semin.Cancer Biol 1999; 9:359-67; http://dx.doi.org/10.1006/scbi.1999.0138
   PubMed Web of Science ®Google Scholar
• Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML. et al. DNA copy number losses in human neoplasms. Am.J.Pathol 1999; 155:683-94; PMID:10487825; http://dx.doi.org/10.1016/S0002-9440(10)65166-8
   PubMed Web of Science ®Google Scholar
• De Strooper LM, van, Zummeren M, Steenbergen RD, Bleeker MC, Hesselink AT, Wisman GB, Snijders PJ, Heideman DA, Meijer CJ. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. J Clin Pathol 2014; 67:1067-71; PMID:25281766; http://dx.doi.org/10.1136/jclinpath-2014-202616
   PubMed Web of Science ®Google Scholar
• Lando M, Holden M, Bergersen LC, Svendsrud DH, Stokke T, Sundfor K, Glad IK, Kristensen GB, Lyng H. Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLoS Genet 2009; 5:e1000719; PMID:19911042; http://dx.doi.org/10.1371/journal.pgen.1000719
   PubMed Web of Science ®Google Scholar
• Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96:294-305; PMID:14970278; http://dx.doi.org/10.1093/jnci/djh031
   PubMed Web of Science ®Google Scholar
• Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ, Snijders PJ, Steenbergen RD. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 2009; 219:327-36; PMID:19662663; http://dx.doi.org/10.1002/path.2598
   PubMed Web of Science ®Google Scholar
• Mine KL, Shulzhenko N, Yambartsev A, Rochman M, Sanson GF, Lando M, Varma S, Skinner J, Volfovsky N, Deng T. et al. Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun 2013; 4:1806; PMID:23651994; http://dx.doi.org/10.1038/ncomms2693
   PubMed Web of Science ®Google Scholar
• Tang MH, Varadan V, Kamalakaran S, Zhang MQ, Dimitrova N, Hicks J. Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions. Front Oncol 2012; 2: 197; PMID:23293768; http://dx.doi.org/10.3389/fonc.2012.00197
   PubMedGoogle Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28; PMID:12042769; http://dx.doi.org/10.1038/nrg962
   PubMed Web of Science ®Google Scholar
• Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-16; PMID:16491070; http://dx.doi.org/10.1038/nrc1799
   PubMed Web of Science ®Google Scholar
• Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG. et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26:16-7; PMID:10973239; http://dx.doi.org/10.1038/79120
   PubMed Web of Science ®Google Scholar
• Myohanen SK, Baylin SB, Herman JG. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 1998; 58:591-3; PMID:9485004
   PubMed Web of Science ®Google Scholar
• Pandis N, Bardi G, Mitelman F, Heim S. Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes Cancer 1997; 18:241-5; PMID:9087563; http://dx.doi.org/10.1002/(SICI)1098-2264(199704)18:4%3c241::AID-GCC1%3e3.0.CO;2-0
   PubMedGoogle Scholar
• Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002; 21:6915-35; PMID:12362274; http://dx.doi.org/10.1038/sj.onc.1205835
   PubMed Web of Science ®Google Scholar
• Lando M, Wilting SM, Snipstad K, Clancy T, Bierkens M, Aarnes EK, Holden M, Stokke T, Sundfor K, Holm R. et al. Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling. J Pathol 2013; 230:59-69; PMID:23335387; http://dx.doi.org/10.1002/path.4168
   PubMedGoogle Scholar
• Ki KD, Lee SK, Tong SY, Lee JM, Song DH, Chi SG. Role of 5′-CpG island hypermethylation of the FHIT gene in cervical carcinoma. J Gynecol Oncol 2008; 19:117-22; PMID:19471558; http://dx.doi.org/10.3802/jgo.2008.19.2.117
   PubMedGoogle Scholar
• Narayan G, Goparaju C, rias-Pulido H, Kaufmann AM, Schneider A, Durst M, Mansukhani M, Pothuri B, Murty VV. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 2006; 5: 16; PMID:16700909; http://dx.doi.org/10.1186/1476-4598-5-16
   PubMed Web of Science ®Google Scholar
• De Strooper LM, Meijer CJ, Berkhof J, Hesselink AT, Snijders PJ, Steenbergen RD, Heideman D. A. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. Cancer Prev Res (Phila) 2014; 7:1251-7; PMID:25281488; http://dx.doi.org/10.1158/1940-6207.CAPR-14-0237
   PubMed Web of Science ®Google Scholar
• Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, Gunderson KL. Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics 2009; 1:177-200; PMID:22122642; http://dx.doi.org/10.2217/epi.09.14
   PubMed Web of Science ®Google Scholar
• Choi CH, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ, Lee JH, Bae DS, Kim BG. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett 2007; 255:26-33; PMID:17467893; http://dx.doi.org/10.1016/j.canlet.2007.03.015
   PubMedGoogle Scholar
• Peng L, Yang Z, Tan C, Ren G, Chen J. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma. Mol Med Rep 2013; 7:1055-61; PMID:23358566
   PubMedGoogle Scholar
• Huang Q, Liu Z, Xie FM, Liu C, Shao F, Zhu CL, Hu S. Fragile histidine triad (FHIT) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway. Scientific World J 2014; 2014: 179698
   Google Scholar
• Ingvarsson S. FHIT alterations in breast cancer. Semin Cancer Biol 2001; 11:361-6; PMID:11562178; http://dx.doi.org/10.1006/scbi.2001.0391
   PubMedGoogle Scholar
• Lung HL, Lo PH, Xie D, Apte SS, Cheung AK, Cheng Y, Law EW, Chua D, Zeng YX, Tsao SW. et al. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 2008; 123:401-8; PMID:18449890; http://dx.doi.org/10.1002/ijc.23528
   PubMedGoogle Scholar
• Lindquist D, Kvarnbrink S, Henriksson R, Hedman H. LRIG and cancer prognosis. Acta Oncol 2014; 53:1135-42; PMID:25180912; http://dx.doi.org/10.3109/0284186X.2014.953258
   PubMed Web of Science ®Google Scholar
• Lindstrom AK, Ekman K, Stendahl U, Tot T, Henriksson R, Hedman H, Hellberg D. LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. Int J Gynecol Cancer 2008; 18:312-7; PMID:17624990; http://dx.doi.org/10.1111/j.1525-1438.2007.01021.x
   PubMed Web of Science ®Google Scholar
• Thompson PA, Ljuslinder I, Tsavachidis S, Brewster A, Sahin A, Hedman H, Henriksson R, Bondy ML, Melin BS. Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer. Cancer Res 2014; 74:2928-35; PMID:24879564; http://dx.doi.org/10.1158/0008-5472.CAN-13-2112
   PubMed Web of Science ®Google Scholar
• Turker MS. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 2002; 21:5388-93; PMID:12154401; http://dx.doi.org/10.1038/sj.onc.1205599
   PubMed Web of Science ®Google Scholar
• Ku GM, Pappalardo F, Luo CC, German MS, McManus MT. An siRNA screen in pancreatic β cells reveals a role for Gpr27 in insulin production. PLoS Genet 2012; 8:e1002449; PMID:22253604; http://dx.doi.org/10.1371/journal.pgen.1002449
   PubMedGoogle Scholar
• Cui J, Yin Y, Ma Q, Wang G, Olman V, Zhang Y, Chou WC, Hong CS, Zhang C, Cao S. et al. Comprehensive characterization of the genomic alterations in human gastric cancer. Int J Cancer 2015; 137:86-95; PMID:25422082; http://dx.doi.org/10.1002/ijc.29352
   PubMedGoogle Scholar
• Etcheverry A, Aubry M, Tayrac M, de, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P. et al. DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics 2010; 11:701; PMID:21156036; http://dx.doi.org/10.1186/1471-2164-11-701
   PubMed Web of Science ®Google Scholar
• De Angelis PM, Clausen OP, Schjolberg A, Stokke T. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999; 80:526-35; PMID:10408863; http://dx.doi.org/10.1038/sj.bjc.6690388
   PubMed Web of Science ®Google Scholar
• Touleimat N, Tost J. Complete pipeline for Infinium((R)) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 2012; 4:325-41; PMID:22690668; http://dx.doi.org/10.2217/epi.12.21
   PubMed Web of Science ®Google Scholar
• Lyng H, Lando M, Brovig RS, Svendsrud DH, Johansen M, Galteland E, Brustugun OT, Meza-Zepeda LA, Myklebost O, Kristensen GB. et al. GeneCount: Genome-wide calculation of absolute tumor DNA copy numbers from array CGH data. Genome Biol 2008; 9:R86; PMID:18500990; http://dx.doi.org/10.1186/gb-2008-9-5-r86
   PubMed Web of Science ®Google Scholar
• Farkas SA, Milutin-Gasperov N, Grce M, Nilsson TK. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. Epigenetics 2013; 8:1213-25; PMID:24030264; http://dx.doi.org/10.4161/epi.26346
   PubMed Web of Science ®Google Scholar
• Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM. et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 2007; 67:4605-19; PMID:17510386; http://dx.doi.org/10.1158/0008-5472.CAN-06-3619
   PubMed Web of Science ®Google Scholar
• Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, Fearon ER, Cho KR. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 2007; 67:10163-72; PMID:17974957; http://dx.doi.org/10.1158/0008-5472.CAN-07-2056
   PubMed Web of Science ®Google Scholar
• Scotto L, Narayan G, Nandula SV, rias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M. et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer 2008; 47:755-65; PMID:18506748; http://dx.doi.org/10.1002/gcc.20577
   PubMed Web of Science ®Google Scholar
• Steenbergen RD, Parker JN, Isern S, Snijders PJ, Walboomers JM, Meijer CJ, Broker TR, Chow LT. Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes. J.Virol 1998; 72:749-57; PMID:9420282
   PubMed Web of Science ®Google Scholar
• Snijders PJ, van, Duin M, Walboomers JM, Steenbergen RD, Risse EK, Helmerhorst TJ, Verheijen RH, Meijer CJ. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res 1998; 58:3812-8; PMID:9731489
   PubMed Web of Science ®Google Scholar
• Bijl J, van Oostveen JW, Kreike M, Rieger E, van der Raaij-Helmer LM, Walboomers JM, Corte G, Boncinelli E, van den Brule AJ, Meijer CJ. Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue. Blood 1996; 87:1737-45; PMID:8634419
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discoveryrate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57:289-300
   Google Scholar